跳转到主要内容
搜索

临床前

注册

最新资源

精选资源

Upcoming preclinical webinars

Latest preclinical blogs

在以下活动中与我们的专家会面

会议

BioTechX EU

2025 年 10 月 6 - 8 日
会议

37th Annual Meeting of the Southern California Chapter Society of Toxicology (SCCSOT)

2025 年 10 月 15 日
会议

ACoP 2025

2025 年 10 月 18 - 21 日

All preclinical resources

Highlights from the FDA Guidance on Dosage Optimization for Therapeutic Radiopharmaceuticals

Biologics, Certara Services, Video

37th Annual Meeting of the Southern California Chapter Society of Toxicology (SCCSOT)

Biologics, Certara Services, Clinical Pharmacology, Drug Development, Drug Safety, Model Informed Drug Development, Therapeutic Specialties, Conference

Certara 大学：Introducing Certara’s Phoenix Cloud TFL Studio: Streamlined Creation of Tables, Figures & Listings

Certara Products - Phoenix, Clinical Pharmacology, Modeling and Simulation - PK/PD, Webinar

Drug Interaction Database (DIDB ®)

Drug-Drug Interactions (DDI), Fact Sheet

临床药理学差距分析最佳实践

Certara Services, Clinical Pharmacology, Modeling and Simulation, Blog

Phoenix® Cloud: 利用人工智能和云端技术加速 PK 科学发展

Certara Products - Phoenix, Brochure

What are the biggest roadblocks still standing in the way of cell and gene therapy commercialization?

Biologics, Cell and Gene Therapy, Certara Services, Therapeutic Specialties, Press Coverage

The Top 10 Things You Need to Know About ADNCA Datasets

CDISC, Certara Products - Phoenix, Certara Services, Clinical Pharmacology, Clinical Trials, Data Standards, Drug Development, Model Informed Drug Development, Modeling and Simulation - PK/PD, Guide

Move Away From Animal-Only Testing May Improve, Speed Rare Disease Research

Certara Services, Drug Development, Rare and Neglected Diseases, Press Coverage

What is a Loading Dose?

Certara 产品 - Phoenix，建模和模拟 - PK/PD，博客，知识库

Dose Optimization using the Gene Therapy Virtual Twin® Platform

Cell and Gene Therapy, Modeling and Simulation - PBPK, Modeling and Simulation - QSP, Blog

AI-driven drug discovery picks up as FDA pushes to reduce animal testing

Certara Services, Drug Development, Press Coverage
订阅时事通讯

为什么订阅？因为改变药物开发不仅是我们的目标，更是我们的执着追求。如果这也是您的想法，那么请第一时间了解新见解，与我们一起推动科学发展。


沪ICP备2022021526号
Powered by Translations.com GlobalLink Web Software